2019 Implementation Science Consortium in Cancer (ISCC)

Please note that as of 2021, this initiative has been renamed from the Implementation Science Consortium in Cancer (ISCC) to the Consortium for Cancer Implementation Science (CCIS)

Outcomes of the 2019 ISCC Meeting

The first Implementation Science Consortium in Cancer (ISCC) meeting focused on developing a new approach to establish an expectation of how the field can work together to address key challenges and identify and develop areas of research that require ongoing relationship and facilitation towards advancing the implementation science agenda in cancer control.

Prajakta Adsul, MBBS, MPH, PhD
National Cancer Institute

Sarah Bruce Bernal, MA
National Cancer Institute

David Chambers, DPhil
National Cancer Institute

Mindy Clyne, MHS, CGC
National Cancer Institute

Graham Colditz, DrPH, MD, MPH
Washington University in St. Louis

Karen Emmons, PhD
Harvard T.H. Chan School of Public Health

Michael Fiore, MD, MPH, MBA
University of Wisconsin School of Medicine and Public Health

Russell Glasgow, PhD, MS
University of Colorado School of Medicine

Muin Khoury, MD, PhD
Centers for Disease Control

Brian Mittman, PhD
Kaiser Permanente Southern California

Gila Neta, PhD, MPP
National Cancer Institute

Wynne Norton, PhD
National Cancer Institute

April Oh, PhD, MPH
National Cancer Institute

Alanna Kulchak Rahm, PhD, MS, LGC

Donna Shelley, MD, MPH
NYU Langone Health

Rachel Shelton, ScD, MPH
Columbia University, Mailman School of Public Health

Jasmin Tiro, PhD
UT Southwestern Medical Center

Robin Vanderpool, DrPH, CHES
University of Kentucky, College of Public Health

Cynthia Vinson, PhD, MPA
National Cancer Institute

Bryan Weiner, PhD
University of Washington

Stephanie Wheeler, PhD, MPH
University of North Carolina, Chapel Hill

Last Updated
October 28, 2020